Skip to main content
Retour
Watch Compare

STRATA Skin Sciences, Inc.

Qualité des données : 100%
SSKN
OTC Manufacturing Measuring & Analyzing Instruments
0,17 €
▼ 0,03 € (-15,00%)
Cap. Boursière: 1,00 M
Prix
0,17 €
Cap. Boursière
1,00 M
Fourchette du Jour
0,17 € — 0,17 €
Fourchette 52 Semaines
0,12 € — 3,86 €
Volume
117
Ouverture 0,17 €
Moyenne 50J / 200J
0,52 €
67,22% below
Moyenne 50J / 200J
1,45 €
88,29% below

Quick Summary

Points Clés

Revenue grew 0,59% annually over 5 years — modest growth
Debt/Equity of 11,65 — high leverage
Negative free cash flow of -4,26 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 9,13%
Capital efficient — spends only 4,78% of revenue on capex

Croissance

Revenue Growth (5Y)
0,59%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)-8,54%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-772,01%
En dessous de la moyenne du secteur (-53,41%)
ROIC-22,92%
Net Margin-20,40%
Op. Margin-15,31%

Sécurité

Debt / Equity
11,65
Au-dessus de la moyenne du secteur (0,31)
Current Ratio0,95
Interest Coverage-2,40

Valorisation

PE (TTM)
-0,16
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio0,76
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,2 -1,5
P/B 0,8 1,6
ROE % -772,0 -53,4
Net Margin % -20,4 -41,5
Rev Growth 5Y % 0,6 1,8
D/E 11,7 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -8,54% Revenue Growth (3Y) -4,07%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 0,59% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 30,70 M Net Income (TTM) -6,26 M
ROE -772,01% ROA -20,38%
Gross Margin 58,25% Operating Margin -15,31%
Net Margin -20,40% Free Cash Flow (TTM) -4,26 M
ROIC -22,92% FCF Growth (3Y) N/A
Safety
Debt / Equity 11,65 Current Ratio 0,95
Interest Coverage -2,40 Asset Turnover 1,00
Working Capital -761 000 Tangible Book Value -4,34 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,16 Forward P/E N/A
P/B Ratio 0,76 P/S Ratio 0,03
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -425,53%
Market Cap 1,00 M Enterprise Value 9,24 M
Per Share
EPS (Diluted TTM) -1,35 Revenue / Share 5,21
FCF / Share -0,72 OCF / Share -0,47
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 4,78% FCF Conversion 68,07%
SBC-Adj. FCF -4,76 M Growth Momentum -9,13

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 30,70 M 33,56 M 33,36 M 36,16 M 29,98 M
Net Income -6,26 M -10,09 M -10,83 M -5,55 M -2,71 M
EPS (Diluted) -1,35 -2,65 -0,31 — —
Gross Profit 17,88 M 19,08 M 18,46 M 21,77 M 19,85 M
Operating Income -4,70 M -9,26 M -8,60 M -4,65 M -4,40 M
EBITDA — — — — —
R&D Expenses 421 000,0 883 000,0 1,32 M 1,03 M 1,43 M
SG&A Expenses — — — — —
D&A 4,12 M 4,97 M 5,55 M 2,40 M 2,10 M
Interest Expense 1,96 M 2,11 M 1,64 M 926 000,0 314 000,0
Income Tax 12 000,0 -170 000,0 -92 000,0 63 000,0 34 000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 30,52 M 36,16 M 42,02 M 52,27 M 46,59 M
Total Liabilities 27,61 M 31,19 M 29,33 M 30,44 M 21,18 M
Shareholders' Equity 2,91 M 4,97 M 12,69 M 21,83 M 25,41 M
Total Debt 15,35 M 15,00 M 15,00 M 8,00 M 8,00 M
Cash & Equivalents 7,91 M 7,26 M 6,78 M 5,43 M 12,59 M
Current Assets 15,60 M 16,60 M 15,54 M 17,50 M 19,97 M
Current Liabilities 26,74 M 14,63 M 12,17 M 13,43 M 12,80 M